Menu Search
Equities

Aptargroup Inc

AGT:MUN

Aptargroup Inc

Actions
  • Price (EUR)135.80
  • Today's Change0.00 / 0.00%
  • Shares traded5.00
  • 1 Year change+23.57%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 07:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.

  • Revenue in USD (TTM)3.54bn
  • Net income in USD312.83m
  • Incorporated1992
  • Employees13.80k
  • Location
    Aptargroup Inc265 EXCHANGE DRIVE, SUITE 301CRYSTAL LAKE 60014United StatesUSA
  • Phone+1 (815) 477-0424
  • Fax+1 (815) 477-0481
  • Websitehttps://www.aptar.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.